APOE and prostate cancer: Unraveling the mechanism by which the dysfunctional apoE isoforms transforms the prostate cancer cell lines to aggressive phenotypes could be a daunting task, which however could be overcome by genetic manipulation under varying physiological conditions, and may provide new insights into the pathogenesis and therapeutic targets of the disease.